Literature DB >> 11517107

Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum.

C Bhatia1, U Pratap, Z Slavik.   

Abstract

Chyloperitoneum is a rare and challenging complication of abdominal surgery. We report a case of iatrogenic chyloperitoneum. Infusion of octreotide, a somatostatin analogue, together with total parenteral nutrition followed by medium chain triglyceride diet resulted in rapid resolution of chyloperitoneum. We believe this to be the first report of successful use of octreotide in iatrogenic chyloperitoneum in a child.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517107      PMCID: PMC1718910          DOI: 10.1136/adc.85.3.234

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

Review 1.  Postoperative chylous ascites: diagnosis and treatment. A series report and literature review.

Authors:  C J Ablan; F N Littooy; R J Freeark
Journal:  Arch Surg       Date:  1990-02

2.  The management of chylous ascites in children.

Authors:  D W Man; L Spitz
Journal:  J Pediatr Surg       Date:  1985-02       Impact factor: 2.545

3.  Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue.

Authors:  J C Reubi; U Horisberger; B Waser; J O Gebbers; J Laissue
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

4.  Aetiology and treatment of chylous ascites.

Authors:  N L Browse; N M Wilson; F Russo; H al-Hassan; D R Allen
Journal:  Br J Surg       Date:  1992-11       Impact factor: 6.939

Review 5.  Chylous ascites in infants and children.

Authors:  S W Unger; J G Chandler
Journal:  Surgery       Date:  1983-03       Impact factor: 3.982

  5 in total
  17 in total

1.  Chylous ascites as a consequence of idiopathic pancreatitis.

Authors:  Chwanrow Karim Baban; Michael Murphy; Cristóir O'Sulleabháin; Deirdre O'Hanlon
Journal:  BMJ Case Rep       Date:  2014-02-05

2.  Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: Answers.

Authors:  Xiaoyan Wu; Molly Vega; Sarah J Swartz; Mini Michael
Journal:  Pediatr Nephrol       Date:  2017-03-10       Impact factor: 3.714

3.  Resolution of chyloperitoneum in a preterm with octreotide, diet and cessation of dialysis.

Authors:  Alper Soylu; Demet Alaygut; Didem Yeşilirmak; Belde Kasap; Mehmet Türkmen; Nuray Duman; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

4.  The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.

Authors:  Dong Xun Zhou; Hua Bang Zhou; Qing Wang; Shan Shan Zou; Hao Wang; He Ping Hu
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

5.  Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease.

Authors:  Kyoung Ah Lim; Sung Hye Kim; June Huh; I-Seok Kang; Heung Jae Lee; Tae-Gook Jun; Pyo Won Park
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 6.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Recurrent chyloperitoneum: a rare complication of peritoneal dialysis.

Authors:  Juhi Kumar; Roberto Gordillo; Marcela Del Rio; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

8.  Treatment and prevention of lymphorrhea after radical gastrectomy of gastric cancer.

Authors:  Lin Sheng-Zhang; Tong Hong-Fei; Ni Zhong-Lin; Yu Yao-Jun; You Tao; Zhang Wei
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-10       Impact factor: 4.553

9.  Management of high-output chylous ascites after D2-lymphadenectomy in patients with gastric cancer: a multi-center study.

Authors:  Enver Ilhan; Uygar Demir; Ali Alemdar; Orhan Ureyen; Yavuz Eryavuz; Mehmet Mihmanli
Journal:  J Gastrointest Oncol       Date:  2016-06

10.  Unconventional management of chyloascites after laparoscopic Nissen fundoplication.

Authors:  Paul F Hwang; Karen A Ospina; Earl H Lee; Scott R Rehring
Journal:  JSLS       Date:  2012 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.